Clinical Trials Directory

Trials / Completed

CompletedNCT07160218

Effects of tDCS and Cognitive Rehabilitation on Cognition and Neural Plasticity in MS Patients

The Effect of Trans-cranial Direct Current Stimulation and Cognitive Rehabilitation on Cognitive Functions and Neuronal Plasticity inPatients With Multiple Sclerosis: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
45 (actual)
Sponsor
Shahid Beheshti University of Medical Sciences · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to evaluate whether transcranial direct current stimulation (tDCS) and cognitive rehabilitation can improve cognitive functions and neuronal plasticity in patients with multiple sclerosis (MS). The participant population consists of MS patients (both sexes, adults), who commonly experience cognitive impairment in addition to physical and psychological symptoms. The main questions it aims to answer are: Does tDCS applied over the left dorsolateral prefrontal cortex improve cognitive abilities in MS patients? Does the combination of tDCS and cognitive rehabilitation enhance neuroplasticity, as measured by DTI, BDNF levels, and acetylcholinesterase activity?

Conditions

Interventions

TypeNameDescription
DEVICEtDCSA 30-minute tDCS session with the cathode placed over the left dorsolateral prefrontal cortex (DLPFC), delivered in 10 sessions over 2 weeks. This protocol targets cognitive improvement in MS patients
DEVICECognitive Rehabilitationcomputer-based cognitive rehabilitation exercises. Conducted in 10 sessions over 2 weeks to enhance attention, memory, and neuroplasticity in MS patients.
DEVICESham tDCSSham stimulation applied over the left DLPFC for 30 minutes, mimicking the sensation of tDCS without delivering active current, over 10 sessions, used as control to blind participants to the intervention

Timeline

Start date
2024-01-02
Primary completion
2025-08-01
Completion
2025-08-15
First posted
2025-09-08
Last updated
2025-09-08

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT07160218. Inclusion in this directory is not an endorsement.